Since 2019, the Comprehensive Cancer Center of the Fundación Jiménez Díaz (FJD) has completed 450 oncologic colorectal operations with just two da Vinci Xi® robots. The platform’s tremor filtration, seven degrees of freedom and high‑definition 3‑D optics extend minimally invasive surgery to deep‑pelvic resections, challenging recurrences and complex transanal approaches. Our median hospital stay is 3‑4 days, and major complications (Clavien‑Dindo ≥ III) remain well below those reported for conventional laparoscopy, mirroring recent meta‑analyses that show fewer conversions to open surgery, reduced blood loss and faster functional recovery with a robotic approach. The unit also contributes to the trial NCT05210647 evaluating long‑term cost‑effectiveness versus laparoscopy, and serves in Spain’s National Proctor Network, providing structured on‑site and virtual mentoring that streamlines the learning curve for surgeons countrywide. This blend of high procedural volume, educational leadership and evidence generation positions the FJD program at the forefront of robotic oncology, delivering precise resections, less postoperative pain and swifter returns to normal life.

References

1. Huang Z et al. Front Oncol. 2023;13:1273378. PMID: 37965455.
2. Robotic versus laparoscopic surgery for rectal cancer: updated meta‑analysis. Int J Colorectal Dis. 2025. PMID: 40022103.
3. Zhang Y et al. Front Surg. 2024;10:1292031. PMID: 38274354.
4. ClinicalTrials.gov. Identifier NCT05210647.